Carcinoma‐associated fibroblasts derive from mesothelial cells via mesothelial‐to‐mesenchymal transition in peritoneal metastasisPilar Sandoval, Manuel López‐Cabrera, Carlos Cabañas et al.|The Journal of Pathology|2013Cited by 183
Mesothelial‐to‐mesenchymal transition in the pathogenesis of post‐surgical peritoneal adhesionsPilar Sandoval, Manuel López‐Cabrera, José A. Jiménez‐Heffernan et al.|The Journal of Pathology|2016Cited by 119
Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancerÁngela Rynne‐Vidal, Manuel López‐Cabrera, Chi Lam Au‐Yeung et al.|The Journal of Pathology|2017Cited by 114
Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Blocks and Reverses Epithelial to Mesenchymal Transition of Mesothelial CellsRaffaele Strippoli, Miguel Á. del Pozo, Ignacio Benedicto et al.|PLoS ONE|2012Cited by 54
Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal TransitionMaría Luisa Pérez‐Lozano, Manuel López‐Cabrera, Pilar Sandoval et al.|PLoS ONE|2013Cited by 43